ArticleQuantitative imaging in medicine and surgery2025
Predictive value of change in percent calcified plaque burden based on serial coronary computed tomographic angiography for cardiovascular events.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plaque progression is an independent risk factor for major adverse cardiovascular events (MACE), and change in the total plaque burden (PB) is a common indicator of plaque progression. However, the type of component (calcification or non-calcification) and the magnitude of changes cannot be determined. We aimed to analyze the capability of the percent calcified PB (PCPB) in reflecting the total and its noncalcified and calcified component PB change, and the predictive value of PCPB for MACE. Methods: Patients who received two or more coronary computed tomographic angiography (CCTA) examinations were included and were divided into MACE and non-MACE groups. The volumes of total plaque, subcomponents and vessel were measured in the serial CCTA. The segmental stenosis score (SSS), high-risk plaque (HRP), total and subcomponent PB, and their annual changes (△PB/year) were calculated. PCPB was calculated as (calcified PB/total PB) × 100%. Results: Totally 116 patients were enrolled in this study, including 26 (22.4%) patients with MACE. The △PCPB/year showed negative correlation with △total PB/year (r=-0.353, P<0.001), ∆noncalcified PB/year (r=-0.591, P<0.001), while positively correlated with △calcified PB/year (r=0.400, P<0.001). If the △PCPB/year covariate was not added, the baseline HRP, Framingham risk score (FRS), and △total PB/year were independent predictors of MACE. Otherwise, the HRP Conclusions: The △PCPB/year index simultaneously reflects changes of the total and its internal compositions PB. Moreover, our study shows the potential of △PCPB/year to predict MACE independently from the annual change of total PB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.